Riskpilot← Back to searchSign inGet full accessSMÅDYRKLINIKK LANGHUS AS
ASActiveOrg 989596330Langhus Senter, 1405 LanghusVeterinary activities · NACE 7500Est. 200611 employees
Revenue 2024
NOK 6,5M
+17% vs 2023
EBITDA margin
-1.9%
-364% vs 2023
Equity ratio
64.0%
Financial strength
Net profit 2024
NOK -327K
-93% vs 2023
| Revenue | NOK 6,5M | +17% |
| EBITDA | NOK -121K | -364% |
| Net profit | NOK -327K | -93% |
| Total assets | NOK 7,1M | +2% |
| Equity | NOK 4,5M | +1% |
| Employees | 11 | — |
Legal name
SMÅDYRKLINIKK LANGHUS AS
Org number
989596330
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
23. mars 2006
Share capital
NOK 200 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Drift av dyrklinikk, herunder salg av varer, tjenester og produkter knyttet til dyrehold, drift av butikk for salg av produkter knyttet dyrehold, samt kurs og opplæringsvirksomhet knyttet til dyrehold
Address
Langhus Senter, 1405 Langhus
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 467 | 4 282 | 4 788 | 5 531 | 6 493 |
| Staff expenses | −1 856 | −1 965 | −2 544 | −3 102 | −3 610 |
| EBITDA | 42 | 313 | 238 | −26 | −121 |
| Depreciation & amort. | −24 | −32 | −39 | −110 | −187 |
| EBIT | 18 | 281 | 199 | −136 | −308 |
| Net financials | −1 | −2 | −0 | 0 | −1 |
| Profit before tax | 17 | 279 | 199 | −136 | −310 |
| Tax | −0 | −429 | −0 | 34 | 18 |
| Net profit | 17 | 708 | 199 | −170 | −327 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 180 | 3 544 | 5 238 | 6 968 | 7 084 |
| Equity | 414 | 2 645 | 4 307 | 4 470 | 4 533 |
| Long-term debt | 0 | 80 | 0 | 1 534 | 1 551 |
| Short-term debt | 766 | 820 | 931 | 964 | 1 000 |
| Total debt | 766 | 900 | 931 | 2 498 | 2 551 |
EBITDA margin
-1.9%
This company
15.8%
Market median
-112% vs market
20202024
Equity ratio
64.0%
This company
38.2%
Market median
+68% vs market
20202024
Return on equity
-7.2%
This company
18.4%
Market median
-139% vs market
20202024
Net profit margin
-5.0%
This company
8.1%
Market median
-162% vs market
20202024
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
20202024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Chairman | 2017 – 2021 | |
| Board of Directors | 2017 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Extended Play As
SMÅDYRKLINIKK LANGHUS AS Board members of SMÅDYRKLINIKK LANGHUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjersti Øiestad | Chairman | 0 companies |
| Siri Øiestad Klynderud | Board of Directors | 0 companies |
| Kristin Elisabeth Engesæth | Chairman | 0 companies |
| Knut Edgar Kleivenes | Board of Directors | 0 companies |